1Bohan A, Peter JB, Bowman RL, Pearson CM. A computer assisted analysis of 153 patients with dermatomyositis and polymyositis.Medicine(Baltiore) 1977;56:255-86.
2Callen JP,Myositis and malignancy.Curr Opin Rheumatol 1994;6:590-4.
3Seda H,Alarcon GS.Musculoskeletal syndromes associated with malignancies.Curr Opin Rheumatol 1995;7:48-53.
4Airio A.Pukala E,Isomaki H.Elevated cancer incidence in patients with dermatomyositis:a populstion based study.J Rheumatol 1994;22:1300-3.
5Schulman P, Kerr LD, Spiera H. Re-examination of the relationship between myositis and malignancy .J Rheumatol 1991; 18: 1689-92.
6Callen JP. The value of malignancy evaluation in patients with dermatomyositis.J Am Acad Dermatol 1982; 6: 253-9.
7Duncan AG,Richardson KB, Klein JB,Targoff IN, Woodcock TM, Callen JP.Clinical.serologic and immunogenetic studies in patients with dermatomyositis.Acta Derm Venereol 1991; 71: 312-6.
8Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyostis sinè myositis). Presentation of six new eases and review of the literature, J Am Acad Dermato1 1991; 24: 939-66.
9Kubo M, Sato S, Kitahara H, Tsuchida T, Tsmaki K. Vesicle formation in dermatomyositis associated with gyoecologic malignancies.J Am Acad Dermatol 1996;34:391-4.
10Leow YH Gob CL. Malignancy in adult dermatomyositis . Int J Dermatol 1997;36:904-7.
